Consistently, patients with HCV and HCC exhibit increased circulating numbers of T regulatory cells, both traditional FoxP3+ and non-traditional CD25- and FoxP3-, and elevated IL10 production. This evidence concerns the gene FOXP3 and hepatocellular carcinoma.